Vaishali Pharma Limited (VAISHALI) - Total Liabilities

Latest as of March 2026: Rs542.74 Million INR ≈ $5.87 Million USD

Based on the latest financial reports, Vaishali Pharma Limited (VAISHALI) has total liabilities worth Rs542.74 Million INR (≈ $5.87 Million USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.

Vaishali Pharma Limited - Total Liabilities Trend (2013–2026)

This chart illustrates how Vaishali Pharma Limited's total liabilities have evolved over time, based on quarterly financial data. See VAISHALI net working capital ratio to evaluate short-term liquidity relative to the company's equity base.

Vaishali Pharma Limited Competitors by Total Liabilities

The table below lists competitors of Vaishali Pharma Limited ranked by their total liabilities.

Company	Country	Total Liabilities
Mercury Industries Bhd KLSE:8192	Malaysia	RM66.01 Million
Bawat Water Technologies AB ST:BAWAT	Sweden	Skr60.22 Million
Welcron Hantec Co.Ltd KQ:076080	Korea	₩96.14 Billion
Eastern Technical Engineering Public Company Limited BK:ETE	Thailand	฿1.40 Billion
hGears AG XETRA:HGEA	Germany	€49.78 Million
Opus One Resources Inc V:OOR	Canada	CA$1.33 Million
Trinity Biotech plc NASDAQ:TRIB	USA	$158.43 Million

Liability Composition Analysis (2013–2026)

This chart breaks down Vaishali Pharma Limited's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see Vaishali Pharma Limited market cap and net worth.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	2.34	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.79	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.44	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Vaishali Pharma Limited's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Vaishali Pharma Limited (2013–2026)

The table below shows the annual total liabilities of Vaishali Pharma Limited from 2013 to 2026.

Year	Total Liabilities	Change
2026-03-31	Rs542.74 Million ≈ $5.87 Million	+20.80%
2025-03-31	Rs449.29 Million ≈ $4.86 Million	+21.05%
2024-03-31	Rs371.16 Million ≈ $4.01 Million	-3.28%
2023-03-31	Rs383.76 Million ≈ $4.15 Million	-30.57%
2022-03-31	Rs552.70 Million ≈ $5.98 Million	-13.24%
2021-03-31	Rs637.05 Million ≈ $6.89 Million	+42.13%
2020-03-31	Rs448.23 Million ≈ $4.85 Million	-5.34%
2019-03-31	Rs473.52 Million ≈ $5.12 Million	+8.30%
2018-03-31	Rs437.22 Million ≈ $4.73 Million	+7.21%
2017-03-31	Rs407.80 Million ≈ $4.41 Million	-12.34%
2016-03-31	Rs465.19 Million ≈ $5.03 Million	+9.30%
2015-03-31	Rs425.60 Million ≈ $4.60 Million	-15.48%
2014-03-31	Rs503.56 Million ≈ $5.45 Million	+9.93%
2013-03-31	Rs458.09 Million ≈ $4.95 Million	--

About Vaishali Pharma Limited

NSE:VAISHALI India Drug Manufacturers - Specialty & Generic

Market Cap

$10.82 Million

Rs1.00 Billion INR

Market Cap Rank

#26848 Global

#1502 in India

Share Price

Rs7.67

Change (1 day)

+2.95%

52-Week Range

Rs4.88 - Rs13.15

All Time High

Rs42.57